作为TNFα抑制剂的一种非典型的副作用:急性多发性心膜炎
Rafael Cantisán-Campillos1, Marcos García-Jambrina2, Estrella Martínez-Bermúdez2
1Cardiología, Hospital San Pedro de Alcántara, España.
Revista espanola de enfermedades digestivas
|January 9, 2025
概括
阿达利穆马布治疗炎症性肠病 (IBD),但可能引起罕见的副作用. 本病例报告详细介绍了一名患者,在开始阿达利穆马布治疗后,他患上了急性胸膜炎.
科学领域:
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
- 心脏病学 心脏病学
背景情况:
- 阿达利穆马布是一种针对瘤亡因子-α (TNF-α) 的生物疗法.
- 它被广泛用于对常规治疗耐药的炎症性肠病 (IBD).
- 了解潜在的不良事件对于患者安全至关重要.
研究的目的:
- 报告与Adalimumab治疗相关的罕见急性多发心膜炎病例.
- 为了突出治疗TNF-α抑制剂的患者潜在的心脏并发症.
主要方法:
- 案例报告的呈现方式.
- 审查患者的病史和治疗过程.
- 对Adalimumab的作用机制和已知的副作用的分析.
主要成果:
- 一名患有性直肠炎的患者出现了急性多发性心膜炎.
- 斑膜硬炎的发病发生在开始Adalimumab治疗后.
- 这表明Adalimumab和多发性心皮炎的发展之间存在潜在的联系.
结论:
- 虽然阿达利穆马布在IBD中有效,但可能与罕见的不良事件有关,例如多发性心膜炎.
- 临床医生应监测治疗Adalimumab的患者的心脏症状.
- 可能需要进一步的研究来阐明这种关联的机制.
相关概念视频
01:28Pleural Effusion II: Symptoms and Management
151
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
151
01:25Pleural Effusion I: Introduction
522
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
522
01:29Pneumonia II: Pathophysiology
212
The pathophysiology of pneumonia involves the following steps:
212
01:27Pneumothorax-II
120
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
120
01:30Pleural Disorders: Types and Brief Description
183
The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
183
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
114
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
114